Study guide
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems
BCSCP Board Certified Sterile Compounding Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, USP Standards & CSP Categories
1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions
2 Chapter 2: Facilities, Engineering Controls & Cleaning
2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures
3 Chapter 3: Environmental Monitoring & Facility Certification
3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols
4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique
4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity
5 Chapter 5: Beyond-Use Dating, Storage & Container Rules
5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules
6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding
6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)
7 Chapter 7: Materials, Equipment & Compounding Workflow
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs
8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility
8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics
9 Chapter 9: Therapeutics, Administration & Patient Monitoring
9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations
10 Chapter 10: Quality Management, Records & Personnel Competency
10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence
11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain
11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
12 Chapter 12: Safety Management, Investigations, Recalls & Waste
12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems
Key Takeaways Explain This Topic AI
USP <797> requires compounding personnel to check the accuracy of an automated compounding device (ACD) or similar equipment before its first use and again each day it is used, keeping a daily record and taking corrective action when results fall outside the manufacturer's specification.
Under USP <41>, a balance is suitable for a weighing when twice the standard deviation of repeated weighings, divided by the net weight, is no more than 0.10%. That sets the balance's minimum weight.
Repeater pumps and ACDs are usually verified gravimetrically: the delivered weight is converted to volume using specific gravity and compared with the target.
IV workflow management systems use barcode scanning, gravimetric checks and image capture to verify each step. ISMP guidance urges moving away from syringe pull-back verification.
All compounding equipment follows SOPs for calibration, maintenance, cleaning and use based on the manufacturer's recommendations, and its records are kept under USP <797> Section 20.
Last updated: September 2026
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems
Modern sterile compounding depends on machines: automated compounding devices (ACDs) for parenteral nutrition, repeater pumps for batching, analytical balances, IV workflow software and, increasingly, robots. The BCSCP outline (task 1A2) expects you to choose them, qualify them, place them correctly and supervise their daily checks.
USP <797> baseline for all equipment (Section 9.1)
Equipment brought into classified areas is wiped with a sporicidal disinfectant, an EPA-registered disinfectant, or sterile 70% IPA using low-lint wipers.
It is placed so that it helps sterile work. Inside a PEC, placement is verified with a smoke pattern test (see 2.5).
It must operate properly and within its performance parameters.
Personnel follow SOPs for calibration, maintenance, cleaning and use , based on the manufacturer's recommendations.
Records of calibration, verification and maintenance are kept as documentation under Section 20.
Automated compounding devices (ACDs)
ACDs pump several source solutions into a final container under computer control. They are standard for PN and are also used for cardioplegia and batch admixtures.
USP <797> requirement: before first use, and again each day it is used to compound CSPs, personnel perform an accuracy assessment . They keep a daily record of the accuracy measurements. Precision is tracked by looking at day-to-day variation in accuracy. If measurements fall outside the manufacturer's specification, corrective action is taken.
Typical good practice around that requirement:
Control Why it matters
Gravimetric accuracy check of each pump channel (or the channels in use) Confirms delivered volume; worked example below
Barcode verification of each source container at hookup and at each change Prevents the wrong solution going on a channel, a known cause of fatal PN errors
Validated sequence (phosphate early, calcium late, with flushes) Limits calcium-phosphate precipitation (see 8.3)
- Final-bag weight compared with expected weight Catches gross delivery errors in each bag
- Tubing sets changed on the manufacturer's schedule Keeps the transfer set sterile and accurate
- Worked gravimetric check
A channel is programmed to deliver 100.0 mL of dextrose 70% (specific gravity about 1.24). Expected mass = 100.0 mL × 1.24 g/mL = 124.0 g \text{Expected mass} = 100.0\,\text{mL} \times 1.24\,\text{g/mL} = 124.0\,\text{g} Expected mass = 100.0 mL × 1.24 g/mL = 124.0 g
The balance reads 122.3 g, so the delivered volume is 122.3 ÷ 1.24 = 98.6 122.3 \div 1.24 = 98.6 122.3 ÷ 1.24 = 98.6 mL, which is 1.4 % 1.4\% 1.4% low. Whether that passes depends on the manufacturer's accuracy specification. Record the result, and if it is out of specification, take the channel out of service and correct it.
Balances (USP <41> and <1251>)
Weighing nonsterile APIs for Category 2 and 3 CSPs, and gravimetric checks, depend on the balance. USP <41> has two tests:
Repeatability: weigh a test weight at least 10 times. The balance is suitable for a weighing if 2 × s m ≤ 0.10 % \frac{2 \times s}{m} \le 0.10\% m 2 × s ≤ 0.10%
where s s s is the standard deviation and m m m is the smallest net weight to be weighed. If s s s is below 0.41 d 0.41d 0.41 d (where d d d is the readability), 0.41 d 0.41d 0.41 d is used instead.
Accuracy: a calibrated test weight between 5% and 100% of capacity must read within 0.10% of its value.
Minimum weight example: readability d = 0.1 d = 0.1 d = 0.1 mg, so 0.41 d = 0.041 0.41d = 0.041 0.41 d = 0.041 mg, and the measured s = 0.05 s = 0.05 s = 0.05 mg. Because s s s is larger than 0.41 d 0.41d 0.41 d , use s s s : m min = 2 × 0.05 mg 0.0010 = 100 mg m_{\min} = \frac{2 \times 0.05\,\text{mg}}{0.0010} = 100\,\text{mg} m m i n = 0.0010 2 × 0.05 mg = 100 mg
Weighings below 100 mg on this balance are not reliable. Use a more precise balance, or use an aliquot method. USP <1251> covers placement (a stable surface away from drafts and vibration), daily checks, and weighing inside containment for hazardous powders.
Repeater pumps and syringe fillers
Peristaltic or syringe repeater pumps fill many syringes or bags with the same volume. Verify the programmed volume gravimetrically at the start of each batch and at intervals during long runs. Prime the sterile tubing set and account for its dead volume. Label the source container on the pump clearly to prevent mix-ups.
IV workflow management systems (IVWMS)
An IVWMS guides the technician step by step. It scans the barcode of every component, may weigh additions (gravimetric verification), photographs key steps, calculates volumes and builds an electronic compounding record . This lets the pharmacist verify remotely from images and data rather than from a syringe pulled back to the dose line.
ISMP's guidelines for safe preparation of compounded sterile preparations recommend moving away from syringe pull-back checking. That method cannot show what was actually injected, from which vial, or whether it was drawn once or twice. Technology-assisted checks are preferred. USP <797> allows the compounding record to be stored electronically in ACD or workflow systems, as long as it is retrievable and contains the required elements.
Robotics
Compounding robots, whether self-contained or placed inside a PEC, need:
- a dynamic smoke pattern test initially and at least every 6 months (USP <797> 4.2.3);
- validated cleaning, including a sporicidal step;
for Category 3, surface sampling at least daily at the end of operations if the robot is a self-enclosed device;
documented dose-accuracy verification and downtime procedures.
Other equipment to keep under control
pH meters: calibrate with standard buffers on each day of use.
Refrigerators, freezers and incubators: monitor temperature continuously or at least daily, and verify the monitoring devices every 12 months if the manufacturer gives no interval. Incubators must sit outside the sterile compounding area.
Air samplers and particle counters: service and calibrate them as the manufacturer recommends.
Autoclaves and depyrogenation ovens: use a calibrated recorder on each cycle, and biological indicators or endotoxin challenge vials as described in 6.1.